12/17/2024
6:00 AM | ESSA Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/17/2024
6:02 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
8:32 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
6:00 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:32 PM | BB BIOTECH AG (Filed by)
ESSA Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
5:56 AM | ESSA Pharma (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/08/2024
3:56 PM | ESSA Pharma (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13D | |
11/07/2024
11:50 AM | BML Investment Partners, L.P. (Filed by)
ESSA Pharma (Subject)
| Form SC 13G | |
11/05/2024
11:06 AM | BB BIOTECH AG (Reporting)
BIOTECH GROWTH N V (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:30 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
2:00 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/09/2024
1:03 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:57 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:00 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:00 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:17 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
9:35 AM | ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
5:16 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
2:02 PM | ESSA Pharma (Subject)
Virsik Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
11:34 AM | ESSA Pharma (Issuer)
Kantoff Philip W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:35 AM | ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:36 AM | ESSA Pharma (Issuer)
Merendino Lauren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:38 AM | ESSA Pharma (Issuer)
Requadt Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:39 AM | ESSA Pharma (Issuer)
Sollis Gary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:40 AM | ESSA Pharma (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:41 AM | ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:25 AM | Cesano Alessandra (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:27 AM | ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:30 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:31 AM | ESSA Pharma (Issuer)
Wood David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:32 AM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:33 AM | ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:18 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:50 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:05 AM | ESSA Pharma (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:01 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/13/2024
5:04 AM | BB BIOTECH AG (Filed by)
ESSA Pharma (Subject)
| Form SC 13G/A | |
02/08/2024
10:29 AM | ESSA Pharma (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
Ignore every stock… (Ad) Stocks have been on a tear in 2024…
And there’s plenty of great opportunities out there.
But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity.
The current GOLD supercycle
You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down.
But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else.
The last time things aligned like this on gold it surged 536% We put together this handy gold guide for you (no cost) so you know what to look for |
02/07/2024
10:29 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:27 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
8:15 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:09 PM | ESSA Pharma (Subject)
Soleus Capital, LLC (Filed by)
| Form SC 13G/A | |
Free EPIX Stock Alerts